Find out what’s hitting the headlines in our pioneering dementia research and how your support is bringing us closer to a cure.
If you have a press enquiry please visit our Press Office page.
The pharmaceutical companies Eisai and Biogen have presented results of a phase 2 clinical trial of the potential Alzheimer’s disease drug, BAN2401. The presentation at the Alzheimer’s Association International Conference 2018 in Chicago, was the first look at data from the trial and follows an earlier announcement of positive results. BAN2401 successfully reduced levels of the […]
Neurology: Association of orthostatic hypotension with incident dementia, stroke, and cognitive decline A team of US scientists have identified an increased dementia risk for people who in midlife experience orthostatic hypotension – unusually high drops in blood pressure when standing up suddenly. The findings were published in the scientific publication, Neurology. Dr Laura Phipps, from […]
Nature Communications: Blood-brain barrier opening in Alzheimer’s disease using MR-guided focussed ultrasound Canadian scientists have shown that a treatment to open the blood brain barrier, which involves implanting an ultrasound treatment alongside an injection of a small gas bubble into the bloodstream is safe in a study of four people with dementia. The findings are […]
Research presented at the Alzheimer’s Association International Conference 2018 today (Wednesday 25 July) has found treating high blood pressure towards the ideal range may help reduce the risk of memory and thinking problems. Carol Routledge, Director of Research at Alzheimer’s Research UK, said: “We know that high blood pressure is a risk factor for dementia, […]
Four new studies being presented at the Alzheimer’s Association International Conference (AAIC) 2018 in Chicago today (Tuesday 24 July) have highlighted a link between the action of the gut and liver, and brain changes associated with Alzheimer’s disease. Fat production in the liver and the link to Alzheimer’s risk Bile acid levels associated with key […]
Dementia researchers from across the globe have gathered in Chicago at the Alzheimer’s Association International Conference (AAIC) 2018. UK-based scientists are presenting their work on the safety of an opioid-based pain killer, buprenorphine, in people living with dementia. The findings reveal that the drug was three times more likely to lead to harmful side effects […]
Dementia describes multiple symptoms that result from a number of diseases in the brain, which are not limited to memory and thinking problems. People with the condition can also experience behavioural and psychological symptoms such as agitation, sleeping problems, hallucinations and anxiety, which can all have a profound effect on their lives. Researchers at the […]
Researchers in Cardiff are inviting members of the public to a free public meeting being held on Wednesday 1 August from 10:00-13:30. The meeting will involve talks from scientists at the forefront of research into dementia and offers the chance to visit a laboratory and put questions to the experts. The public event is organised […]
He may be better known for his bursts of speed down a rugby pitch, but England’s record try-scorer Rory Underwood will be tackling a longer distance this weekend in a bid to raise money for dementia research. Rory, who scored 49 tries in 85 Tests between 1984 and 1996, is taking on the Prudential RideLondon-Surrey […]
Dementia risk linked to pregnancies and reproductive history More women than men are affected by dementia, and in the UK women make up two thirds of those living with the condition. While women can expect to live longer than men, this alone does not explain the difference in the numbers developing dementia, and scientists have […]